Jubilant Pharmova releases Q2 and H1 2025 financials

Jubilant Pharmova Limited announced the publication of its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The results were reviewed by the audit committee and subsequently approved by the board of directors at a meeting held on October 31, 2025.

The company has made these financial results, along with the auditor's reports, accessible to investors through various platforms. They are available on Jubilant Pharmova’s website, the National Stock Exchange of India (NSE) website, and the Bombay Stock Exchange (BSE) website. Investors can also access the results by scanning a QR code provided in the publication.

This announcement was made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Copies of the announcement appeared in the Financial Express (English) and Hindustan (Hindi) newspapers on November 1, 2025. Priyavrat Bhartia, managing director, signed the announcement on behalf of the board of directors.